Significant loss of pyramidal neurons in the angular gyrus of patients with Huntington's disease

Neuropathology and Applied Neurobiology

Volumn 23, Issue 6, 1997, Pages 492-495

  Macdonald, V ^a   Halliday, G M ^a   Trent, R J ^b   McCusker, E A ^c  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Immunohistochemistry; Neurofilament; Neuropathology; Parietal lobe; Quantification

Indexed keywords

ANTIBODY; PEROXIDASE;

ANGULAR GYRUS; ANTIGEN RETRIEVAL; ARTICLE; AUTOPSY; BRAIN CORTEX; CAUDATE NUCLEUS; CELL COUNT; CELL LOSS; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; FROZEN SECTION; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; MALE; NERVE PROJECTION; NEUROPATHOLOGY; PARIETAL LOBE; PRIMATE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

EID: 0031446053     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1997.tb01326.x     Document Type: Article

References (15)

1. Campbell MJ, Morrison JH. Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J Comp Neurol 1989; 282: 191-205
2. Cudkowicz M, Kowall NW. Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann Neurol 1990; 27: 200-4
3. Evers P, Uylings HBM. Effects of microwave pretreatment on immunocytochemical staining of vibratome sections and tissue blocks of human cerebral cortex stored in formaldehyde fixative for long periods. J Neurosci Meth 1995; 55: 163-72
4. Gold M, Adair JC, Jacobs DH, Heilman KM. Right-left confusion in Gerstmann's syndrome: a model of body centred spatial orientation. Cortex 1995; 31: 267-83
5. Gottron F, Turetsky D, Choi D. SMI-32 antibody against nonphosphorylated neurofilaments identifies a subpopulation of cultured cortical neurons hypersensitive to kainate toxicity. Neurosci Lett 1995; 194: 1-4
6. Harasty J, Double KL, Halliday GM, Kril JJ, McRitchie DA. Language-associated cortical regions are proportionally larger in the female brain. Arch Neurol 1997; 54: 171-6
7. Jernigan TL, Salmon DP, Butters N, Hesselink JR. Cerebral structure on MRI, Part II. Specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry 1991; 29: 68-81
8. Kremer B, Weber B, Hayden MR. New insights into the clinical features, pathogenesis and molecular genetics of Huntington's disease. Brain Pathol 1992; 2: 321-35
9. Kuwert T, Lange HW, Langen K, Herzog H, Aulich A, Feinendegen LE. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 1990; 113: 1405-23
10. Mann DMA, Oliver R, Snowden JS. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol 1993; 85: 553-9
11. Oorschoot DE. Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go. Prog Neurobiol 1994; 44: 233-47
12. Pierrot-Deseilligny CH, Rivaud S, Gaymard B, Agid Y. Cortical control of reflexive visually-guided saccades. Brain 1991; 114: 1473-85
13. Sotrel A, Paskevich PA, Kiely DK, Bird ED, Williams RS, Myers RH. Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 1991; 41: 1117-23
14. Vonsattel J. Neuropathology of Huntington's disease. In Movement Disorders in Neurology and Neuropsychiatry, Eds AB Joseph, RR Young. Boston: Blackwell Science, 1992: 186-94
15. Yeterian EH, Pandya DN. Striatal connections of the parietal association cortices in rhesus monkeys. J Comp Neurol 1993; 332: 175-97